| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on January 23, 2005
From the Department of Pharmacology, Faculty of Pharmaceutical Sciences and High Technology Research Center, Kobe Gakuin University, Ikawadani-cho, Nishi-ku, Kobe, Japan. * To whom correspondence should be addressed. E-mail: yayama{at}pharm.kobegakuin.ac.jp.
Abstract--To evaluate the role of vascular angiotensin II (Ang II) type 2 (AT2) receptor in renovascular hypertension, we investigated expressions of AT2 receptor and endothelial nitric oxide synthase (eNOS) in thoracic aortas of mice with 2-kidney, 1-clip (2K1C) hypertension. The mRNA levels of AT2 receptor in aortas, but not those of AT1 and bradykinin B2 receptors, increased 14 days but not 42 days after clipping. The contractile response to Ang II (>0.1 µmol/L) was attenuated in aortic rings excised 14 days after clipping and was restored to that of rings from sham mice by antagonists of AT2 receptor (PD123319) and B2 receptor (icatibant). The aortic levels of total eNOS, phosphorylated eNOS at Ser1177 (p-eNOS), total Akt, and phosphorylated Akt at Ser473 (p-Akt) were increased in 2K1C mice on day 14, whereas only eNOS levels were increased on day 42. The aortic cGMP levels were
Revised on February 18, 2005
Angiotensin Type 2 Receptor-Mediated Phosphorylation of eNOS in the Aortas of Mice With 2-Kidney, 1-Clip Hypertension
Hiromi Hiyoshi;
20-fold greater in 2K1C mice on day 14 compared with sham mice. Administration of nicardipine for 4 days before the excision of aortas 14 days after clipping not only reduced blood pressure but also decreased the aortic levels of eNOS, p-eNOS, Akt, p-Akt, and cGMP to sham levels, whereas the administration of PD123319 or icatibant to 2K1C mice decreased p-eNOS and cGMP to sham levels without affecting blood pressure and the levels of eNOS, Akt and p-Akt. These results suggest that vascular NO production is enhanced by increased eNOS phosphorylation via the activation of AT2 receptors in the course of 2K1C hypertension.
This article has been cited by other articles:
![]() |
K. Tsuda Angiotensin AT2 Receptor-Mediated Neuroprotection and Nitric Oxide-Bioavailability in Stroke Stroke, July 1, 2009; 40(7): e493 - e493. [Full Text] [PDF] |
||||
![]() |
C. A. McCarthy, A. Vinh, J. K. Callaway, and R. E. Widdop Response to Letter by Tsuda Stroke, July 1, 2009; 40(7): e494 - e494. [Full Text] [PDF] |
||||
![]() |
F. Helle, M. Hultstrom, T. Skogstrand, F. Palm, and B. M. Iversen Angiotensin II-induced contraction is attenuated by nitric oxide in afferent arterioles from the nonclipped kidney in 2K1C Am J Physiol Renal Physiol, January 1, 2009; 296(1): F78 - F86. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Palm, S. G. Connors, M. Mendonca, W. J. Welch, and C. S. Wilcox Angiotensin II Type 2 Receptors and Nitric Oxide Sustain Oxygenation in the Clipped Kidney of Early Goldblatt Hypertensive Rats Hypertension, February 1, 2008; 51(2): 345 - 351. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Welch, K. Patel, P. Modlinger, M. Mendonca, N. Kawada, K. Dennehy, S. Aslam, and C. S. Wilcox Roles of vasoconstrictor prostaglandins, COX-1 and -2, and AT1, AT2, and TP receptors in a rat model of early 2K,1C hypertension Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2644 - H2649. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Wagenseil, R. H. Knutsen, D. Y. Li, and R. P. Mecham Elastin-insufficient mice show normal cardiovascular remodeling in 2K1C hypertension despite higher baseline pressure and unique cardiovascular architecture Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H574 - H582. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, X. Zhao, X. Li, K. M. Lerea, and S. C. Olson Angiotensin II type 2 receptor-dependent increases in nitric oxide synthase expression in the pulmonary endothelium is mediated via a G{alpha}i3/Ras/Raf/MAPK pathway Am J Physiol Cell Physiol, June 1, 2007; 292(6): C2185 - C2196. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Toda, K. Ayajiki, and T. Okamura Interaction of Endothelial Nitric Oxide and Angiotensin in the Circulation Pharmacol. Rev., March 1, 2007; 59(1): 54 - 87. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Suzuki, K. Eguchi, H. Ohtsu, S. Higuchi, S. Dhobale, G. D. Frank, E. D. Motley, and S. Eguchi Activation of Endothelial Nitric Oxide Synthase by the Angiotensin II Type 1 Receptor Endocrinology, December 1, 2006; 147(12): 5914 - 5920. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yayama, H. Hiyoshi, D. Imazu, and H. Okamoto Angiotensin II Stimulates Endothelial NO Synthase Phosphorylation in Thoracic Aorta of Mice With Abdominal Aortic Banding Via Type 2 Receptor Hypertension, November 1, 2006; 48(5): 958 - 964. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Carey and J. Park Role of Angiotensin Type 2 Receptors in Vasodilation of Resistance and Capacitance Vessels Hypertension, November 1, 2006; 48(5): 824 - 825. [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |